LRMR - Wall Street Estimates - Larimar Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 3.34

2.77 %

$ 213 M

Market Cap

-2.9

P/E

Price Target Average

468.86%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

31.54%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Larimar Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for LRMR of $19 , with forecasts ranging from a low of $14 to a high of $25 .

LRMR Lowest Price Target Wall Street Target

14 USD 319.16%

LRMR Average Price Target Wall Street Target

19 USD 468.86%

LRMR Highest Price Target Wall Street Target

25 USD 648.50%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free